WP
ALXN
WMS Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-2,275
| Closed | -$272K | – | 240 |
|
|
2017
Q4 | $272K | Buy |
2,275
+170
| +8% | +$20.3K | 0.03% | 193 |
|
|
2017
Q3 | $295K | Hold |
2,105
| – | – | 0.04% | 172 |
|
|
2017
Q2 | $256K | Sell |
2,105
-5
| -0.2% | -$608 | 0.03% | 181 |
|
|
2017
Q1 | $256K | Hold |
2,110
| – | – | 0.03% | 172 |
|
|
2016
Q4 | $258K | Buy |
2,110
+5
| +0.2% | +$611 | 0.03% | 163 |
|
|
2016
Q3 | $258K | Hold |
2,105
| – | – | 0.03% | 165 |
|
|
2016
Q2 | $246K | Sell |
2,105
-1,500
| -42% | -$175K | 0.03% | 180 |
|
|
2016
Q1 | $502K | Buy |
3,605
+163
| +5% | +$22.7K | 0.07% | 114 |
|
|
2015
Q4 | $657K | Buy |
3,442
+87
| +3% | +$16.6K | 0.09% | 102 |
|
|
2015
Q3 | $525K | Buy |
3,355
+671
| +25% | +$105K | 0.08% | 107 |
|
|
2015
Q2 | $485K | Buy |
2,684
+544
| +25% | +$98.3K | 0.06% | 173 |
|
|
2015
Q1 | $371K | Buy |
2,140
+35
| +2% | +$6.07K | 0.05% | 192 |
|
|
2014
Q4 | $389K | Hold |
2,105
| – | – | 0.06% | 136 |
|
|
2014
Q3 | $349K | Sell |
2,105
-405
| -16% | -$67.1K | 0.05% | 170 |
|
|
2014
Q2 | $392K | Sell |
2,510
-550
| -18% | -$85.9K | 0.06% | 161 |
|
|
2014
Q1 | $466K | Buy |
3,060
+1,305
| +74% | +$199K | 0.07% | 147 |
|
|
2013
Q4 | $233K | Buy |
+1,755
| New | +$233K | 0.04% | 202 |
|